HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlos Fernández de Larrea Selected Research

Leukocyte Immunoglobulin-like Receptor B1

1/2018Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlos Fernández de Larrea Research Topics

Disease

20Multiple Myeloma
04/2022 - 01/2011
8Immunoglobulin Light-chain Amyloidosis
12/2021 - 02/2008
5Neoplasms (Cancer)
04/2022 - 11/2018
5Monoclonal Gammopathy of Undetermined Significance
10/2021 - 01/2015
5Disease Progression
01/2021 - 07/2011
4Tuberculosis (Tuberculoses)
01/2021 - 03/2002
3Paraproteinemias (Monoclonal Gammopathy)
04/2021 - 02/2009
3Hemorrhage
10/2020 - 02/2008
3Smoldering Multiple Myeloma
01/2018 - 03/2016
3Amyloidosis
12/2017 - 01/2017
3Pathologic Complete Response
01/2014 - 01/2011
2Lymphoma (Lymphomas)
04/2022 - 01/2021
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 01/2020
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
04/2021 - 10/2020
2Infections
10/2020 - 04/2013
1Leukemia
04/2022
1Hematologic Neoplasms (Hematological Malignancy)
12/2021
1Cytokine Release Syndrome
07/2021
1Thrombotic Microangiopathies
01/2021
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2021
1Atrial Fibrillation
10/2020
1Contusions
10/2020
1Diarrhea
10/2020
1Edema (Dropsy)
10/2020
1Neutropenia
10/2020
1Pneumonia (Pneumonitis)
10/2020
1Spasm (Spasms)
10/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020
1Fever (Fevers)
01/2020
1Plasmacytoma
05/2019
1Bites and Stings (Sting)
11/2018
1Pain (Aches)
10/2018
1Amyloid Plaque
04/2015
1Transthyretin-Related Hereditary Amyloidosis
04/2015
1Pulmonary Tuberculosis
04/2013
1Residual Neoplasm
07/2012
1Pleural Effusion (Pleural Effusions)
03/2011

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
04/2022 - 07/2012
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 02/2009
4Chimeric Antigen ReceptorsIBA
12/2021 - 11/2018
4B-Cell Maturation AntigenIBA
12/2021 - 01/2020
4bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
12/2021 - 01/2020
4Bortezomib (Velcade)FDA Link
11/2021 - 02/2009
4Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2018
3Amyloid (Amyloid Fibrils)IBA
12/2021 - 04/2015
3Lenalidomide (CC 5013)FDA Link
01/2021 - 09/2015
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 02/2008
3AntigensIBA
11/2018 - 09/2008
3Immunoglobulins (Immunoglobulin)IBA
03/2016 - 01/2011
2Monoclonal AntibodiesIBA
04/2022 - 11/2018
2Immunoglobulin M (IgM)IBA
04/2021 - 12/2017
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 09/2015
2Complement System Proteins (Complement)IBA
01/2021 - 12/2003
2Peptides (Polypeptides)IBA
01/2021 - 04/2013
2Immunoglobulin G (IgG)IBA
10/2018 - 02/2009
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
06/2018 - 09/2015
2Oligoclonal BandsIBA
08/2017 - 01/2011
2Tuberculin (PPD)IBA
12/2003 - 03/2002
1Melphalan (Alkeran)FDA LinkGeneric
11/2021
1Interleukin-2 (IL2)IBA
07/2021
1CytokinesIBA
07/2021
1Interleukin-15 (Interleukin 15)IBA
07/2021
1Proteasome InhibitorsIBA
01/2021
1Etoposide (VP 16)FDA LinkGeneric
01/2021
1Thalidomide (Thalomid)FDA Link
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1carfilzomibIBA
01/2021
1ibrutinibIBA
10/2020
1Agammaglobulinaemia Tyrosine KinaseIBA
10/2020
1zanubrutinibIBA
10/2020
1LigandsIBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1NectinsIBA
01/2020
1poliovirus receptorIBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1pomalidomideIBA
05/2019
1ParaproteinsIBA
05/2019
1Pharmaceutical PreparationsIBA
11/2018
1AntibodiesIBA
11/2018
1Immune Checkpoint InhibitorsIBA
11/2018
1Leukocyte Immunoglobulin-like Receptor B1IBA
01/2018
1Diphosphonates (Bisphosphonates)IBA
03/2016
1Immunomodulating AgentsIBA
09/2015
1Amyloidogenic ProteinsIBA
04/2015
1MicroRNAs (MicroRNA)IBA
01/2015
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2014
1ImmunosorbentsIBA
04/2013
1EnzymesIBA
04/2013
1Interleukin-12 Subunit p40IBA
03/2011

Therapy/Procedure

9Therapeutics
12/2021 - 02/2009
9Stem Cell Transplantation
01/2020 - 02/2008
3Transplantation
08/2017 - 07/2012
2Immunotherapy
07/2021 - 11/2018
2Hematopoietic Stem Cell Mobilization
02/2009 - 02/2008
1Kidney Transplantation
11/2021
1Patient Readmission
01/2020
1Aftercare (After-Treatment)
12/2017
1Hematopoietic Stem Cell Transplantation
07/2012
1Induction Chemotherapy
01/2011